Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stryker BMP Putty Receives HDE Approval For Spine Applications

This article was originally published in The Gray Sheet

Executive Summary

Stryker will extend its OP-1 bone morphogenic protein into the revision spine surgery market following recent humanitarian device exemption clearance of a putty form, the firm announced April 8

You may also be interested in...



Stryker Spine Putty Approval “Significantly” Delayed, Firm Says

FDA is requesting additional data to support Stryker's OP-1 Putty PMA, which could delay approval of the posterolateral lumbar spine fusion surgery indication until 2009, the firm says

Stryker Spine Putty Approval “Significantly” Delayed, Firm Says

FDA is requesting additional data to support Stryker's OP-1 Putty PMA, which could delay approval of the posterolateral lumbar spine fusion surgery indication until 2009, the firm says

Stryker Bets On OP-1 Putty After Encountering A Tough Orthopedic Climate

Stryker says that its OP-1 Putty bone morphogenetic protein will sustain growth levels as its hips and knee products encounter an increasingly challenging pricing environment

Related Content

UsernamePublicRestriction

Register

MT020069

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel